A three-year collaboration between Pfizer and the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), has resulted in a new AI-driven drug discovery method that could ...
In recent years, artificial intelligence programs for drug design have steadily shown they can help explore far beyond just ...
Researchers developed a method to assess the ability of small molecules to bind to hundreds of human proteins using AI and ML ...
Researchers tested a research-based intervention with English learners with math difficulty. The intervention proved to boost comprehension and help students synthesize and visualize information, ...
For most human proteins, there are no small molecules known to bind them chemically (so-called "ligands"). Ligands frequently ...